Free Trial

Connor Clark & Lunn Investment Management Ltd. Purchases Shares of 36,210 Sabra Healthcare REIT, Inc. $SBRA

Sabra Healthcare REIT logo with Finance background

Key Points

  • Connor Clark & Lunn Investment Management Ltd. has acquired 36,210 shares of Sabra Healthcare REIT, Inc., valued at approximately $633,000, indicating increased interest in the REIT sector.
  • Sabra Healthcare REIT reported $0.38 earnings per share for the last quarter, surpassing analysts' expectations of $0.36, with a year-over-year revenue increase of 7.4%.
  • The company declared a quarterly dividend of $0.30 per share, representing a 6.4% dividend yield, with a high dividend payout ratio of 157.89%.
  • MarketBeat previews the top five stocks to own by October 1st.

Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 36,210 shares of the real estate investment trust's stock, valued at approximately $633,000.

Other large investors have also recently added to or reduced their stakes in the company. Jefferies Financial Group Inc. increased its stake in shares of Sabra Healthcare REIT by 7,196.8% during the 1st quarter. Jefferies Financial Group Inc. now owns 1,466,000 shares of the real estate investment trust's stock worth $25,611,000 after purchasing an additional 1,445,909 shares during the last quarter. Northern Trust Corp increased its stake in shares of Sabra Healthcare REIT by 27.7% during the 4th quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock worth $72,214,000 after purchasing an additional 905,466 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Sabra Healthcare REIT during the 4th quarter worth $14,241,000. Wellington Management Group LLP increased its stake in shares of Sabra Healthcare REIT by 33.7% during the 4th quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock worth $55,511,000 after purchasing an additional 808,207 shares during the last quarter. Finally, Nuveen Asset Management LLC increased its stake in shares of Sabra Healthcare REIT by 30.8% during the 4th quarter. Nuveen Asset Management LLC now owns 3,378,733 shares of the real estate investment trust's stock worth $58,520,000 after purchasing an additional 795,902 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Healthcare REIT Stock Performance

NASDAQ:SBRA traded down $0.07 during midday trading on Friday, reaching $19.55. The stock had a trading volume of 3,551,550 shares, compared to its average volume of 2,712,781. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The firm's fifty day simple moving average is $18.45 and its 200-day simple moving average is $17.69. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The stock has a market capitalization of $4.69 billion, a P/E ratio of 25.72, a PEG ratio of 1.56 and a beta of 0.86.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. During the same period last year, the business posted $0.36 EPS. Sabra Healthcare REIT's revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.1%. Sabra Healthcare REIT's dividend payout ratio is 157.89%.

Analyst Upgrades and Downgrades

SBRA has been the topic of several analyst reports. JMP Securities increased their price target on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. Scotiabank increased their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research note on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $20.00.

Get Our Latest Research Report on Sabra Healthcare REIT

About Sabra Healthcare REIT

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Featured Articles

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Healthcare REIT Right Now?

Before you consider Sabra Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.

While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.